Copyright
©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6236-6245
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6236
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6236
Table 5 Histological characteristics (76 patients) n (%)
| Pre-anti viral treatment | Post-anti viral treatment | P value | |
| Fibrosis stage (n = 76)(based on the Scheuer scheme) | |||
| Stage 0-2 | 65 (86) | 41 (54) | < 0.001 |
| Stage 3-4 | 11 (14) | 35 (46) | |
| Grade (n = 76) | |||
| Grade 0-2 | 51 (67) | 46 (61) | 0.33 |
| Grade 3-4 | 25 (33) | 30 (39) | |
| Degree of steatosis (brunt classification) (n = 78) | |||
| Score 0-1 | 69 (88) | 73 (94) | 0.29 |
| Score 2-3 | 9 (12) | 5 (6) | |
| Steatohepatitis grade (n = 75) | |||
| Grade 0 | 69 (92) | 71 (95) | 0.73 |
| Grade 1-2 | 6 (8) | 4 (5) | |
| Steatohepatitis stage (n = 75) | |||
| Stage 0-1 | 72 (96) | 73 (97) | 1.00 |
| Stage 2-4 | 3 (4) | 2 (3) |
- Citation: Lim KB, Sima HR, Fiel MI, Khaitova V, Doucette JT, Chernyiak M, Ahmad J, Bach N, Chang C, Grewal P, Kim-Schluger L, Liu L, Odin J, Perumalswami P, Florman SS, Schiano TD. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus. World J Gastroenterol 2015; 21(20): 6236-6245
- URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6236